Healthcare Global Enterprises is currently trading at Rs. 193.40, up by 4.45 points or 2.36% from its previous closing of Rs. 188.95 on the BSE.
The scrip opened at Rs. 187.00 and has touched a high and low of Rs. 201.00 and Rs. 187.00 respectively.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 338.00 on 15-Feb-2018 and a 52 week low of Rs. 182.00 on 07-Jan-2019.
Last one week high and low of the scrip stood at Rs. 202.85 and Rs. 186.60 respectively. The current market cap of the company is Rs. 1687.89 crore.
The promoters holding in the company stood at 24.10%, while Institutions and Non-Institutions held 58.02% and 17.88% respectively.
Healthcare Global Enterprises (HCG) will acquire the remaining 46,695 equity shares, constituting 49.9% of the share capital of BACC Healthcare (BACC) from Dr. Rao. The company currently holds 50.1% of the share capital of BACC, which it acquired in March, 2013.
On acquiring the Shares, BACC would become a wholly owned subsidiary of the company. BACC operates fertility treatment centres under the brand ‘Milann’. Dr. Rao will continue to serve as the Medical Director of Milann.
HCG is the largest provider of cancer care in India. Through its network of comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 6694.40 |
Max Healthcare Inst | 1039.35 |
Narayana Hrudayalay | 1287.85 |
Aster DM Healthcare | 489.85 |
Global Health | 1023.35 |
View more.. |